Drs. Scott Larsen and James Shayman receive funding for moving small molecule into clinical development

Drs. Larsen and Shayman plan to use this grant to fund Investigational New Drug (IND)-enabling studies on their best compounds, which they hope will lead directly to clinical trials Scott Larsen, Ph.D., Joseph Burckhalter Collegiate Research Professor of Medicinal Chemistry, Read on! →